Walgreens Boots Alliance on Wednesday declared a regular quaterly dividend of 33.75 cents per share.
Family Dollar Stores reported a 3% lift in second-quarter revenue with same-store sales up 0.5%.
Strong same-store sales help lift Rite Aid annual revenue 3.9% to $26.5 billion.
Rite Aid's March results spurred a 3% lift in its share price Thursday morning.
Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed.
Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.
The two companies will merge to create The Kraft Heinz Company, resulting in a portfolio that will make the newly formed entity a food-and-beverage powerhouse.
Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.
Rite Aid will fund in part the cash portion of its acquisition of EnvisionRx through the offering of $1.8 billion in senior unsecured notes due 2023.
Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.